Phototherapy in the management of vitiligo – an updated narrative review

Authors

  • Adam Wełniak Students’ Scientifc Club of Dermatology, Department of Dermatology and Venerology, Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland https://orcid.org/0000-0001-6473-3068
  • Aleksandra Białczyk Students’ Scientifc Club of Dermatology, Department of Dermatology and Venerology, Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland https://orcid.org/0000-0003-4735-2356
  • Barbara Kamińska Students’ Scientifc Club of Dermatology, Department of Dermatology and Venerology, Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland https://orcid.org/0000-0002-0332-3038
  • Rafał Czajkowski Department of Dermatology and Venerology, Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland https://orcid.org/0000-0003-3418-1252

DOI:

https://doi.org/10.15584/ejcem.2024.3.26

Keywords:

NB-UVB, phototherapy, vitiligo

Abstract

Introduction and aim. Vitiligo is a chronic skin disease characterized by progressive loss of melanocytes. Various treatment options have been developed to manage vitiligo, however, phototherapy has emerged as one of the most effective treatment options. Therefore, this review has been written to examine the mechanisms of this particular treatment approach and its optimal implementation.

Material and methods. A review of the literature regarding combination of word vitiligo with the following: psoralen ultraviolet A (PUVA), narrowband ultraviolet B (NB-UVB) and excimer laser (EL) was performed using the PubMed database.

Analysis of the literature. NB-UVB has demonstrated safety and efficacy in stimulating melanocyte proliferation and melanin synthesis, making it an attractive treatment option for both localized and generalized vitiligo. PUVA therapy, combining psoralen photosensitization with UVA irradiation, has shown remarkable efficacy in repigmentation, particularly in refractory or extensive vitiligo. However, because of possible side effects, it is not recommended as a first line phototherapy. With its targeted and precise approach, EL offers a localized treatment and has produced impressive results in localized and segmented vitiligo.

Conclusion. Despite limitations, phototherapy continues to evolve, offering hope for individuals with vitiligo. Further research and advancements in treatment protocols are needed.

Downloads

Download data is not yet available.

References

Diotallevi F, Gioacchini H, De Simoni E, et al. Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art. Int J Mol Sci. 2023;24(5):4910. doi:10.3390/ijms24054910

Zhang Y, Cai Y, Shi M, et al. The Prevalence of Vitiligo: A Meta-Analysis. PLoS One. 2016;11(9):e0163806. doi:10.1371/journal.pone.0163806

Bae JM, Jung HM, Hong BY, et al. Phototherapy for Vitiligo: A Systematic Review and Meta-analysis. JAMA Dermatol. 2017;153(7):666-674. doi:10.1001/jamadermatol.2017.0002

Czajkowski R, Placek W, Flisiak I, et al. Vitiligo. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Dermatology Review. 2019;106(1):1-15. doi:10.5114/dr.2019.83440

Post NF, Ezekwe N, Narayan VS, et al. The use of lasers in vitiligo, an overview. J Eur Acad Dermatol Venereol. 2022;36(6):779-789. doi:10.1111/jdv.18005

Esmat S, Hegazy RA, Shalaby S, Hu SC, Lan CE. Phototherapy and Combination Therapies for Vitiligo. Dermatol Clin. 2017;35(2):171-192. doi:10.1016/j.det.2016.11.008

Richard EG. The Science and (Lost) Art of Psoralen Plus UVA Phototherapy. Dermatol Clin. 2020;38(1):11-23. doi:10.1016/j.det.2019.08.002

Vieyra-Garcia PA, Wolf P. A deep dive into UV-based phototherapy: Mechanisms of action and emerging molecular targets in inflammation and cancer. Pharmacol Ther. 2021;222:107784. doi:10.1016/j.pharmthera.2020.107784

Ibbotson SH. A Perspective on the Use of NB-UVB Phototherapy vs. PUVA Photochemotherapy. Front Med (Lausanne). 2018;5:184. doi:10.3389/fmed.2018.00184

Shenoi SD, Prabhu S; Indian Association of Dermatologists, Venereologists and Leprologists. Photochemotherapy (PUVA) in psoriasis and vitiligo. Indian J Dermatol Venereol Leprol. 2014;80(6):497-504. doi:10.4103/0378-6323.144143

Krenitsky A, Ghamrawi RI, Feldman SR. Phototherapy: a Review and Update of Treatment Options in Dermatology. Curr Derm Rep. 2020:9;10-21. doi:10.1007/s13671-020-00290-6

Anbar TS, El-Sawy AE, Attia SK, et al. Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study. Photodermatol Photoimmunol Photomed. 2012;28(1):17-25. doi:10.1111/j.1600-0781.2011.00631.x

Zhang Y, Mooneyan-Ramchurn JS, Zuo N, Feng Y, Xiao S. Vitiligo nonsurgical treatment: a review of latest treatment researches. Dermatol Ther. 2014;27(5):298-303. doi:10.1111/dth.12143

Cunningham KN, Rosmarin D. Vitiligo Treatments: Review of Current Therapeutic Modalities and JAK Inhibitors. Am J Clin Dermatol. 2023;24(2):165-186. doi:10.1007/s40257-022-00752-6

Bertolani M, Rodighiero E, de Felici Del Giudice MB, Lotti T, Feliciani C, Satolli F. Vitiligo: What's old, what's new. Dermatol Reports. 2021;13(2):9142. doi:10.4081/dr.2021.9142

Babes A, Kichko TI, Selescu T, et al. Psoralens activate and photosensitize Transient Receptor Potential channels Ankyrin type 1 (TRPA1) and Vanilloid type 1 (TRPV1). Eur J Pain. 2021;25(1):122-135. doi:10.1002/ejp.1654

Wyckmans M, Bervoets A. A review on PUVA pricks-A debilitating adverse event. Photodermatol Photoimmunol Photomed. 2023;39(3):185-192. doi:10.1111/phpp.12824

Singh S, Khandpur S, Sharma VK, Ramam M. Comparison of efficacy and side-effect profile of oral PUVA vs. oral PUVA sol in the treatment of vitiligo: a 36-week prospective study. J Eur Acad Dermatol Venereol. 2013;27(11):1344-1351. doi:10.1111/jdv.12002

Barros NM, Sbroglio LL, Buffara MO, Baka JLCES, Pessoa AS, Azulay-Abulafia L. Phototherapy. An Bras Dermatol. 2021;96(4):397-407. doi:10.1016/j.abd.2021.03.001

Liu X, Yao Z, Wang Y, Chai L, Zhou X. Vitamin D analogs combined with different types of phototherapy in the treatment of vitiligo: A systematic review of randomized trials and within-patient studies. Int Immunopharmacol. 2022;109:108789. doi:10.1016/j.intimp.2022.108789

Khanna U, Khandpur S. What Is New in Narrow-Band Ultraviolet-B Therapy for Vitiligo?. Indian Dermatol Online J. 2019;10(3):234-243. doi:10.4103/idoj.IDOJ_310_18

Harrop G, Dawe RS, Ibbotson S. Are photosensitizing medications associated with increased risk of important erythemal reactions during ultraviolet B phototherapy?. Br J Dermatol. 2018;179(5):1184-1185. doi:10.1111/bjd.16800

Mohammad TF, Al-Jamal M, Hamzavi IH, et al. The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo. J Am Acad Dermatol. 2017;76(5):879-888. doi:10.1016/j.jaad.2016.12.041

Silpa-Archa N, Weerasubpong P, Junsuwan N, Yothachai P, Supapueng O, Wongpraparut C. Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo. J Dermatolog Treat. 2019;30(7):691-696. doi:10.1080/09546634.2018.1544409

Alshiyab D, Al-Qarqaz F, Ba-Shammakh S, et al. Comparison of the efficacy of tacrolimus 0.1% ointment vs calcipotriol/betamethasone in combination with NBUVB in treatment of vitiligo. J Dermatolog Treat. 2023;34(1):2252119. doi:10.1080/09546634.2023.2252119

Seneschal J, Speeckaert R, Taïeb A, et al. Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force-Part 2: Specific treatment recommendations. J Eur Acad Dermatol Venereol. 2023;37(11):2185-2195. doi:10.1111/jdv.19450

Yang TT, Chiu SH, Lan CE. The effects of UVB irradiance on vitiligo phototherapy and UVB-induced photocarcinogenesis. Photodermatol Photoimmunol Photomed. 2020;36(4):257-262. doi:10.1111/phpp.12536

Said ER, Nagui NAER, Rashed LA, Mostafa WZ. Oxidative stress and the cholinergic system in non-segmental vitiligo: Effect of narrow band ultraviolet b. Photodermatol Photoimmunol Photomed. 2021;37(4):306-312. doi:10.1111/phpp.12653

Lin F, Sun X, Lei J, Xu AE. Altered circulating memory T cells in vitiligo cases followed NB-UVB therapy. Photodermatol Photoimmunol Photomed. 2022;38(1):76-82. doi:10.1111/phpp.12719

Errichetti E, Zelin E, Pinzani C, Kyrgidis A, Lallas A, Stinco G. Dermoscopic and Clinical Response Predictor Factors in Nonsegmental Vitiligo Treated with Narrowband Ultraviolet B Phototherapy: A Prospective Observational Study. Dermatol Ther (Heidelb). 2020;10(5):1089-1098. doi:10.1007/s13555-020-00431-6

Zhang L, Wang X, Chen S, et al. Comparison of efficacy and safety profile for home NB-UVB vs. outpatient NB-UVB in the treatment of non-segmental vitiligo: A prospective cohort study. Photodermatol Photoimmunol Photomed. 2019;35(4):261-267. doi:10.1111/phpp.12462

Bae JM, Ju HJ, Lee RW, et al. Evaluation for Skin Cancer and Precancer in Patients With Vitiligo Treated With Long-term Narrowband UV-B Phototherapy. JAMA Dermatol. 2020;156(5):529-537. doi:10.1001/jamadermatol.2020.0218

Zhu B, Liu C, Zhang L, Wang J, Chen M, Wei Y. Comparison of NB-UVB combination therapy regimens for vitiligo: A systematic review and network meta-analysis. J Cosmet Dermatol. 2023;22(3):1083-1098. doi:10.1111/jocd.15534

Gharib K, Ibrahim A, El Sharkawi Y, Elmegrab N, Attia M. Methotrexate Gel Either Alone or Combined with Narrow Band Ultraviolet B or Excimer Light for the Treatment of Vitiligo. J Clin Aesthet Dermatol. 2023;16(3):32-36.

Neinaa YME, Mahmoud MAE, El Maghraby GM, Ibrahim ZAE. Efficacy of prostaglandin E2 versus prostaglandin F2 alpha assisted with narrowband-UVB in stable vitiligo. Arch Dermatol Res. 2023;315(9):2647-2653. doi:10.1007/s00403-023-02700-8

Song H, Hu Z, Zhang S, Yang L, Liu Y, Wang T. Effectiveness and safety of tofacitinib combined with narrowband ultraviolet B phototherapy for patients with refractory vitiligo in real-world clinical practice. Dermatol Ther. 2022;35(11):e15821. doi:10.1111/dth.15821

Sun XK, Xu AE. Repigmentation of acral vitiligo with tofacitinib combined with NB-UVB phototherapy: A case report. Australas J Dermatol. 2023;64(4):571-572. doi:10.1111/ajd.14147

Yousefian F, Yadlapati S, Browning JC. The use of Janus kinase inhibitors and narrowband ultraviolet B combination therapy in non-segmental vitiligo. J Cosmet Dermatol. 2023;22(3):1105-1107. doi:10.1111/jocd.15537

Zabolinejad N, Maleki M, Salehi M, Ashrafi Z, Molkara S, Layegh P. Psoralen and narrowband UVB combination provides higher efficacy in treating vitiligo compared with narrowband UVB alone: A randomised clinical trial. Australas J Dermatol. 2020;61(1):65-69. doi:10.1111/ajd.13184

Hum M, Kalia S, Gniadecki R. Prescribing Home Narrowband UVB Phototherapy: A Review of Current Approaches. J Cutan Med Surg. 2019;23(1):91-96. doi:10.1177/1203475418800947

Liu B, Sun Y, Song J, Wu Z. Home vs hospital narrowband UVB treatment by a hand-held unit for new-onset vitiligo: A pilot randomized controlled study. Photodermatol Photoimmunol Photomed. 2020;36(1):14-20. doi:10.1111/phpp.12495

Singh S, Khandpur S, Sharma VK, Bhari N, Pandey RM. An Open-Label Non-Randomized Preliminary Noninferiority Study Comparing Home-Based Handheld Narrow-Band UVB Comb Device with Standard Hospital-Based Whole-Body Narrow-Band UVB Therapy in Localized Vitiligo. Indian Dermatol Online J. 2023;14(4):510-515. doi:10.4103/idoj.idoj_604_22

Mofty ME, Zaher H, Esmat S, et al. PUVA and PUVB in vitiligo--are they equally effective?. Photodermatol Photoimmunol Photomed. 2001;17(4):159-163. doi:10.1034/j.1600-0781.2001.170403.x

Bansal S, Sahoo B, Garg V. Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone. Photodermatol Photoimmunol Photomed. 2013;29(6):311-317. doi:10.1111/phpp.12072

Zabolinejad N, Maleki M, Salehi M, Ashrafi Z, Molkara S, Layegh P. Psoralen and narrowband UVB combination provides higher efficacy in treating vitiligo compared with narrowband UVB alone: A randomised clinical trial. Australas J Dermatol. 2020;61(1):65-69. doi:10.1111/ajd.13184

Ly K, Smith MP, Thibodeaux QG, Beck KM, Liao W, Bhutani T. Beyond the Booth: Excimer Laser for Cutaneous Conditions. Dermatol Clin. 2020;38(1):157-163. doi:10.1016/j.det.2019.08.009

Yeon J, Doolan BJ, Schultz A, Gupta M. Australian experience and practical approach to the 308-nm excimer light therapy in dermatology. Australas J Dermatol. 2022;63(2):240-243. doi:10.1111/ajd.13842

Park KK, Liao W, Murase JE. A review of monochromatic excimer light in vitiligo. Br J Dermatol. 2012;167(3):468-478. doi:10.1111/j.1365-2133.2012.11008.x

Baltás E, Csoma Z, Ignácz F, Dobozy A, Kemény L. Treatment of vitiligo with the 308-nm xenon chloride excimer laser. Arch Dermatol. 2002;138(12):1619-1620.

Mavilia L, Mori M, Rossi R, Campolmi P, Puglisi Guerra A, Lotti T. 308 nm monochromatic excimer light in dermatology: personal experience and review of the literature. G Ital Dermatol Venereol. 2008;143(5):329-337.

Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE; Vitiligo Working Group. Current and emerging treatments for vitiligo. J Am Acad Dermatol. 2017;77(1):17-29. doi: 10.1016/j.jaad.2016.11.010

Noborio R, Nomura Y, Nakamura M, et al. Efficacy of 308-nm excimer laser treatment for refractory vitiligo: a case series of treatment based on the minimal blistering dose. J Eur Acad Dermatol Venereol. 2021;35(4):287-289. doi:10.1111/jdv.17047

Kim JC, Kim HR, Park JS, et al. Vitamin D supplementation can enhance therapeutic effects of excimer laser in patients with vitiligo. J Cosmet Dermatol. 2024;23(3):839-848. doi:10.1111/jocd.16043

Bae JM, Hann S-K. Laser Treatments for Vitiligo. Med Lasers. 2016;5:63-70. doi:10.25289/ML.2016.5.2.63

Fenniche S, Zaouak A, Tanfous AB, Jrad M, Hammami H. Successful Treatment of Refractory Vitiligo with a Combination of Khellin and 308-nm Excimer Lamp: An Open-Label, 1-Year Prospective Study. Dermatol Ther (Heidelb). 2018;8(1):127-135. doi:10.1007/s13555-017-0218-x

Bae JM, Eun SH, Oh SH, et al. The 308-nm excimer laser treatment does not increase the risk of skin cancer in patients with vitiligo: A population-based retrospective cohort study. Pigment Cell Melanoma Res. 2019;32(5):714-718. doi:10.1111/pcmr.12781

Ju HJ, Han JH, Kim MS, et al. The long-term risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo. J Am Acad Dermatol. 2021;84(6):1619-1627. doi:10.1016/j.jaad.2021.01.067

Mehraban S, Feily A. 308nm excimer laser in dermatology. J Lasers Med Sci. 2014;5(1):8-12.

Gianfaldoni S, Tchernev G, Wollina U, et al. Vitiligo in Children: What's New in Treatment?. Open Access Maced J Med Sci. 2018;6(1):221-225. doi:10.3889/oamjms.2018.060

Bae JM, Hong BY, Lee JH, Lee JH, Kim GM. The efficacy of 308-nm excimer laser/light (EL) and topical agent combination therapy versus EL monotherapy for vitiligo: A systematic review and meta-analysis of randomized controlled trials (RCTs). J Am Acad Dermatol. 2016;74(5):907-915. doi:10.1016/j.jaad.2015.11.044

Deng Y, Li J, Yang G. 308-nm Excimer Laser Plus Platelet-Rich Plasma for Treatment of Stable Vitiligo: A Prospective, Randomized Case-Control Study. Clin Cosmet Investig Dermatol. 2020;13:461-467. doi:10.2147/CCID.S260434

Chen J, Yu N, Li H, Tang Y, Zhu H. Meta-analysis of the efficacy of adding platelet-rich plasma to 308-nm excimer laser for patients with vitiligo. J Int Med Res. 2022;50(9):3000605221119646. doi:10.1177/03000605221119646

Chang HC, Sung CW. Efficacy of combination therapy of narrowband-ultraviolet B phototherapy or excimer laser with topical tacrolimus for vitiligo: An updated systematic review and meta-analysis. Photodermatol Photoimmunol Photomed. 2021;37(1):74-77. doi:10.1111/phpp.12593

Kawalek AZ, Spencer JM, Phelps RG. Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study. Dermatol Surg. 2004;30(2 Pt 1):130-135. doi:10.1111/j.1524-4725.2004.30058.x

Nisticò S, Chiricozzi A, Saraceno R, Schipani C, Chimenti S. Vitiligo treatment with monochromatic excimer light and tacrolimus: results of an open randomized controlled study. Photomed Laser Surg. 2012;30(1):26-30. doi:10.1089/pho.2011.3029

Passeron T, Ostovari N, Zakaria W, et al. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. Arch Dermatol. 2004;140(9):1065-1069. doi:10.1001/archderm.140.9.1065

Li C, Hu Y, Mu Z, et al. Comparison of various excimer laser (EL) combination therapies for vitiligo: a systematic review and network meta-analysis. J Dermatolog Treat. 2024;35(1):2302064. doi:10.1080/09546634.2024.2302064

Zhou F, Chen S, Jin W, Lu Y, Gao Y, Wu J. Comparison of the efficacy and safety of 308-nm excimer laser as monotherapy and combination therapy with topical tacrolimus in the treatment of periocular vitiligo. Dermatol Ther. 2022;35(7):e15556. doi:10.1111/dth.15556

Downloads

Published

2024-09-30

How to Cite

Wełniak, A., Białczyk, A., Kamińska, B., & Czajkowski, R. (2024). Phototherapy in the management of vitiligo – an updated narrative review. European Journal of Clinical and Experimental Medicine, 22(3), 668–676. https://doi.org/10.15584/ejcem.2024.3.26

Issue

Vol. 22 No. 3 (2024)

Section

REVIEW PAPERS

License

Copyright (c) 2024 European Journal of Clinical and Experimental Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.

All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.